Upgrade to SI Premium - Free Trial

Seres Therapeutics (MCRB)

2.30 -0.01 (0.43%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Seres Therapeutics to present SER-428 preclinical data at IDWeek October 15, 2026 7:02 AM - StreetInsider Seres Therapeutics to Present Preclinical Data for SER-428, an Investigational Live Biotherapeutic Designed to Reduce Risk of Bloodstream Infections in Critically Ill Patients, at IDWeek 2026 October 15, 2026 7:00 AM - Globe NewsWire Form EFFECT Seres Therapeutics, Inc. August 24, 2026 6:05 AM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Aug 15 Filed by: Brady Kelly August 18, 2026 5:33 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Aug 15 Filed by: Shaff Eric D. August 18, 2026 5:28 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Aug 15 Filed by: Henn Matthew R August 18, 2026 5:26 PM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Aug 15 Filed by: DesRosier Thomas August 18, 2026 5:23 PM - SEC Filing Seres Therapeutics (MCRB) files $300M mixed shelf August 13, 2026 4:36 PM - StreetInsider Form S-3 Seres Therapeutics, Inc. August 13, 2026 4:35 PM - SEC Filing Form 10-Q Seres Therapeutics, Inc. For: Jun 30 August 5, 2026 10:31 AM - SEC Filing Seres Therapeutics (MCRB) Tops Q2 EPS by 277c August 5, 2026 7:09 AM - StreetInsider Form 8-K Seres Therapeutics, Inc. For: Aug 05 August 5, 2026 7:05 AM - SEC Filing Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs August 5, 2026 7:01 AM - Globe NewsWire Form 8-K Seres Therapeutics, Inc. For: Jul 31 August 4, 2026 4:04 PM - SEC Filing Form 424B5 Seres Therapeutics, Inc. August 4, 2026 4:02 PM - SEC Filing Full Article List